Boston Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-855
| Closed | -$268K | – | 631 |
|
|
2019
Q2 | $268K | Sell |
855
-10,688
| -93% | -$3.35M | 0.01% | 584 |
|
|
2019
Q1 | $4.74M | Sell |
11,543
-5,165
| -31% | -$2.12M | 0.24% | 114 |
|
|
2018
Q4 | $6.24M | Buy |
16,708
+8,710
| +109% | +$3.25M | 0.36% | 67 |
|
|
2018
Q3 | $3.23M | Buy |
7,998
+7,267
| +994% | +$2.94M | 0.14% | 230 |
|
|
2018
Q2 | $252K | Sell |
731
-5,985
| -89% | -$2.06M | 0.01% | 603 |
|
|
2018
Q1 | $2.31M | Buy |
6,716
+1,810
| +37% | +$623K | 0.06% | 263 |
|
|
2017
Q4 | $1.84M | Sell |
4,906
-360
| -7% | -$135K | 0.04% | 288 |
|
|
2017
Q3 | $2.36M | Sell |
5,266
-430
| -8% | -$192K | 0.05% | 277 |
|
|
2017
Q2 | $2.8M | Buy |
5,696
+465
| +9% | +$228K | 0.06% | 274 |
|
|
2017
Q1 | $2.03M | Sell |
5,231
-1,921
| -27% | -$744K | 0.05% | 284 |
|
|
2016
Q4 | $2.63M | Sell |
7,152
-325
| -4% | -$119K | 0.06% | 281 |
|
|
2016
Q3 | $3.01M | Buy |
7,477
+80
| +1% | +$32.2K | 0.07% | 251 |
|
|
2016
Q2 | $2.58M | Buy |
7,397
+1,095
| +17% | +$382K | 0.06% | 258 |
|
|
2016
Q1 | $2.27M | Buy |
6,302
+303
| +5% | +$109K | 0.06% | 255 |
|
|
2015
Q4 | $3.26M | Buy |
5,999
+518
| +9% | +$281K | 0.08% | 236 |
|
|
2015
Q3 | $2.55M | Sell |
5,481
-947
| -15% | -$440K | 0.1% | 239 |
|
|
2015
Q2 | $3.28M | Sell |
6,428
-78
| -1% | -$39.8K | 0.14% | 172 |
|
|
2015
Q1 | $2.94M | Buy |
6,506
+3,585
| +123% | +$1.62M | 0.12% | 191 |
|
|
2014
Q4 | $1.2M | Buy |
2,921
+125
| +4% | +$51.3K | 0.05% | 246 |
|
|
2014
Q3 | $1.01M | Buy |
2,796
+5
| +0.2% | +$1.8K | 0.04% | 273 |
|
|
2014
Q2 | $788K | Sell |
2,791
-74
| -3% | -$20.9K | 0.03% | 304 |
|
|
2014
Q1 | $860K | Buy |
2,865
+195
| +7% | +$58.5K | 0.04% | 284 |
|
|
2013
Q4 | $735K | Sell |
2,670
-7,995
| -75% | -$2.2M | 0.04% | 302 |
|
|
2013
Q3 | $3.34M | Buy |
10,665
+85
| +0.8% | +$26.6K | 0.18% | 134 |
|
|
2013
Q2 | $2.38M | Buy |
+10,580
| New | +$2.38M | 0.11% | 155 |
|